Corporate Banner
Satellite Banner
Biomolecular Screening
Scientific Community
 
Become a Member | Sign in
Home>Events>This Event
  Events - September 2014


Biosimilars and Biobetters

29 Sep 2014 - 30 Sep 2014 - London, UK



Bookmark and Share


The industry leading Biosimilars & Biobetters Conference for combining new biosimilars and biobetter developments with essential networking opportunities, will be taking place in London, on the 29th-30th of September 2014. 

With an in-depth focus on the current and future landscape of the biosimilars market, this year's conference will allow input from key industry experts in the field to engage in meaningful and important discussions on how to accelerate drug development to market.

Join this event and be part of a major networking opportunity providing intimate interaction with your peers, where you will hear case studies, presentations and round table discussions on the key issues surrounding biosimilar commercial and manufacturing developments.

KEY TOPICS INCLUDE:

  • Optimizing the commercial potential of biosimilars in Europe 
  • The big guns are coming! ...how will the entry of originator companies impact the biosimilars industry 
  • What is on the horizon? ... Reviewing the opportunities and challenges for the biopharmaceutical industry 
  • Christening day…but what shall we call you! Discussing the ongoing debate on naming biosimilars... and much more!

KEY SPEAKERS INCLUDE:

  • Alan Sheppard, Global Head Generics, Thought Leadership, IMS Health 
  • Richard Dicicco, Chairman, Harvest Moon Pharmaceuticals 
  • Uwe Gudat, Head of Safety Biosimilars, Merck Switzerland Limited 
  • Catherine Akers, Regulatory Affairs Manager, Amgen Inc  
  • Carsten Brockmeyer, Founder, Formycon AG 
  • Rakesh Dixit, Vice President, R&D, Global Head, Biologics Safety Assessment, Medimmune (AstraZeneca Biologics) 
  • Ineke Braat, CEO, Pan-Generika 
  • Sharma Alok, Principal Scientist & Head Analytical Development, Lupin Laboratories Ltd 
  • Steinar Madsen, Medical Director, Norwegian Medicines Agency 
  • Peter Wittner, Senior Consultant, Interpharm Consultancy 
  • Sarah Faircliffe, Legal Director, Bird & Bird...

Plus, many more at this year's event.

For more information, contact Fateja Begum on +44 (0) 207 827 6184 or e-mail fbegum@smi-online.co.uk

For sponsorship enquiries, contact Alia Malick on +44 (0) 207 827 6168 or e-mail amalick@smi-online.co.uk

Event website: www.smi-online.co.uk/2014biosimilars65.asp



Further information
Scientific News
Insights into the Function of the Main Class of Drug Targets
About thirty percent of all medical drugs such as beta-blockers or antidepressants interact with certain types of cell surface proteins called G protein coupled receptors.
Visualizing a Cancer Drug Target at Atomic Resolution
Using cryo-electron microscopy, researchers were able to view, in atomic detail, the binding of a potential small molecule drug to a key protein in cancer cells.
Honey’s Potential to Save Lives
The healing powers of honey have been known for thousands of years.
3-D Printed Lifelike Liver Tissue for Drug Screening
A team led by engineers at the University of California, San Diego has 3D-printed a tissue that closely mimics the human liver's sophisticated structure and function. The new model could be used for patient-specific drug screening and disease modeling.
Cytoskeleton Crew
Findings confirm sugar's role in helping cancers survive by changing cellular architecture.
Biomarker for Recurring HPV-Linked Oropharyngeal Cancers
A look-back analysis of HPV infection antibodies in patients treated for oropharyngeal (mouth and throat) cancers linked to HPV infection suggests at least one of the antibodies could be useful in identifying those at risk for a recurrence of the cancer, say scientists at the Johns Hopkins University.
Valvena, GSK Sign New R&D Collaboration
Valneva to supply process development services for EB66® -based Influenza vaccines.
Light Signals from Living Cells
Fluorescent protein markers delivered under high pressure.
Cellular 'Relief Valve'
A team led by scientists at The Scripps Research Institute (TSRI) has solved a long-standing mystery in cell biology by showing essentially how a key “relief-valve” in cells does its job.
Genomic Signature Shared by Five Types of Cancer
National Institutes of Health researchers have identified a striking signature in tumor DNA that occurs in five different types of cancer.
Scroll Up
Scroll Down
SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,900+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,200+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!